Global study finds new medication for sinus thrombosis is just as safe but more patient-friendly

Updated on: March 28,2025 0

Global study finds new medication for sinus thrombosis is just as safe but more patient-friendly

Updated on:March 28,2025 0

Study yields unexpected results from empagliflozin after heart attack

Updated on: March 28,2025 0

Study yields unexpected results from empagliflozin after heart attack

Updated on:March 28,2025 0

Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds

Updated on: March 28,2025 0

Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds

Updated on:March 28,2025 0

Novel computational tool for identifying synergistic drug combinations developed

Updated on: March 28,2025 0

Novel computational tool for identifying synergistic drug combinations developed

Updated on:March 28,2025 0

FDA approves Romvimza for tenosynovial giant cell tumor (TGCT)

Updated on: March 28,2025 0

FDA approves Romvimza for tenosynovial giant cell tumor (TGCT)

Updated on:March 28,2025 0

California clinicians boost buprenorphine prescriptions, aiding recovery efforts

Updated on: March 28,2025 0

California clinicians boost buprenorphine prescriptions, aiding recovery efforts

Updated on:March 28,2025 0

Talazoparib and enzalutamide tied to improved overall survival in metastatic prostate cancer

Updated on: March 28,2025 0

Talazoparib and enzalutamide tied to improved overall survival in metastatic prostate cancer

Updated on:March 28,2025 0

Novel antibiotic BTZ-043 can also target TB bacteria hiding in dead lung tissue

Updated on: March 28,2025 0

Novel antibiotic BTZ-043 can also target TB bacteria hiding in dead lung tissue

Updated on:March 28,2025 0

Study reveals split opinions on long-term opioid use for chronic pain

Updated on: March 27,2025 0

Study reveals split opinions on long-term opioid use for chronic pain

Updated on:March 27,2025 0

Paxlovid's promise fades: Vaccinated seniors see minimal COVID-19 protection

Updated on: March 27,2025 0

Paxlovid's promise fades: Vaccinated seniors see minimal COVID-19 protection

Updated on:March 27,2025 0